Lin, Yen-Nien
Ibrahim, Ahmed
Marbán, Eduardo
Cingolani, Eugenio
Funding for this research was provided by:
China Medical University (CMU107-N-05)
National Institutes of Health (R01 HL124074, R01 HL135866, R01 HL147570)
DOD Peer Reviewed Medical Research Program (PR150620)
Article History
Received: 20 November 2020
Accepted: 11 May 2021
First Online: 4 June 2021
Declarations
:
: E.M. owns founder’s equity in Capricor Therapeutics.